Sun Z, Cai S, Liu X, Jiang W, Ye L
Cancer Diagn Progn. 2024; 4(5):567-578.
PMID: 39238632
PMC: 11372696.
DOI: 10.21873/cdp.10365.
He K, Meng X, Su J, Jiang S, Chu M, Huang B
Heliyon. 2024; 10(5):e27028.
PMID: 38449659
PMC: 10915379.
DOI: 10.1016/j.heliyon.2024.e27028.
Wu Q, Zheng Z, Zhang J, Piao Z, Xin M, Xiang X
Front Oncol. 2022; 12:862751.
PMID: 35494000
PMC: 9046701.
DOI: 10.3389/fonc.2022.862751.
You J, Wang W, Chang H, Yi Y, Zhao H, Zhu H
Front Cell Dev Biol. 2021; 9:607332.
PMID: 33614644
PMC: 7889606.
DOI: 10.3389/fcell.2021.607332.
Zhu F, Li H, Ding F, Guo H, Mou H, Ma J
Am J Transl Res. 2020; 12(8):4693-4701.
PMID: 32913542
PMC: 7476107.
Multi-Omics Analysis Reveals the Pan-Cancer Landscape of Bone Morphogenetic Proteins.
Luo W, Luo M, He R, Ying L, Luo J
Med Sci Monit. 2020; 26:e920943.
PMID: 32248202
PMC: 7156877.
DOI: 10.12659/MSM.920943.
Deregulated bone morphogenetic proteins and their receptors are associated with disease progression of gastric cancer.
Sun Z, Liu C, Jiang W, Ye L
Comput Struct Biotechnol J. 2020; 18:177-188.
PMID: 31988704
PMC: 6965205.
DOI: 10.1016/j.csbj.2019.12.014.
Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein.
NeMoyer R, Mondal A, Vora M, Langenfeld E, Glover D, Scott M
Cell Commun Signal. 2019; 17(1):150.
PMID: 31744505
PMC: 6862756.
DOI: 10.1186/s12964-019-0469-5.
Sclerostin domain-containing protein 1 is dispensable for the differentiation of follicular helper and follicular regulatory T cells during acute viral infection.
Hu J, Wu J, Li Y, Wang Z, Tang J, Li Z
Am J Transl Res. 2019; 11(6):3722-3736.
PMID: 31312383
PMC: 6614606.
Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer.
Johnstone C, Pattison A, Gorringe K, Harrison P, Powell D, Lock P
Dis Model Mech. 2018; 11(5).
PMID: 29720474
PMC: 5992606.
DOI: 10.1242/dmm.032250.
Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.
Newman J, Augeri D, NeMoyer R, Malhotra J, Langenfeld E, Chesson C
Oncogene. 2018; 37(27):3672-3685.
PMID: 29622797
PMC: 10905627.
DOI: 10.1038/s41388-018-0156-9.
Bone morphogenetic protein 2 promotes human trophoblast cell invasion by upregulating N-cadherin via non-canonical SMAD2/3 signaling.
Zhao H, Klausen C, Li Y, Zhu H, Wang Y, Leung P
Cell Death Dis. 2018; 9(2):174.
PMID: 29416020
PMC: 5833391.
DOI: 10.1038/s41419-017-0230-1.
Bone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance.
Zabkiewicz C, Resaul J, Hargest R, Jiang W, Ye L
Endocr Relat Cancer. 2017; 24(10):R349-R366.
PMID: 28733469
PMC: 5574206.
DOI: 10.1530/ERC-17-0139.
Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
Jiramongkolchai P, Owens P, Hong C
Biochem Soc Trans. 2016; 44(4):1117-34.
PMID: 27528760
PMC: 5483997.
DOI: 10.1042/BST20160069.
Bone morphogenetic protein signaling in musculoskeletal cancer.
Bami M, Mavrogenis A, Angelini A, Milonaki M, Mitsiokapa E, Stamoulis D
J Cancer Res Clin Oncol. 2016; 142(10):2061-72.
PMID: 27043154
DOI: 10.1007/s00432-016-2149-9.
Chordin-Like 1 Suppresses Bone Morphogenetic Protein 4-Induced Breast Cancer Cell Migration and Invasion.
Cyr-Depauw C, Northey J, Tabaries S, Annis M, Dong Z, Cory S
Mol Cell Biol. 2016; 36(10):1509-25.
PMID: 26976638
PMC: 4859683.
DOI: 10.1128/MCB.00600-15.
A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.
James A, LaChaud G, Shen J, Asatrian G, Nguyen V, Zhang X
Tissue Eng Part B Rev. 2016; 22(4):284-97.
PMID: 26857241
PMC: 4964756.
DOI: 10.1089/ten.TEB.2015.0357.
A Molecular View of Pathological Microcalcification in Breast Cancer.
Sharma T, Radosevich J, Pachori G, Mandal C
J Mammary Gland Biol Neoplasia. 2016; 21(1-2):25-40.
PMID: 26769216
DOI: 10.1007/s10911-015-9349-9.
Association Between BMP-2 and Carcinogenicity.
Skovrlj B, Koehler S, Anderson P, Qureshi S, Hecht A, Iatridis J
Spine (Phila Pa 1976). 2015; 40(23):1862-71.
PMID: 26274524
PMC: 7423158.
DOI: 10.1097/BRS.0000000000001126.
Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response.
Chapellier M, Bachelard-Cascales E, Schmidt X, Clement F, Treilleux I, Delay E
Stem Cell Reports. 2015; 4(2):239-54.
PMID: 25601208
PMC: 4325271.
DOI: 10.1016/j.stemcr.2014.12.007.